RxDoctor Payments Data

Jessica Burich

Psychiatric/Mental Health · Saint Louis, MONPI 1003268152

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,734 of the $7,862 with a category attached, or 85.7%. It is spread thinly across 22 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,862in general payments, 2019–2025

Across 378 payments — averaging $20.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corium, LLC$1K
  • AbbVie$1K
  • Axsome Therapeutics, Inc.$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$821
  • Otsuka America Pharmaceutical, Inc.$512
  • Teva Pharmaceuticals USA, Inc.$425
  • plus $2K from 16 others

What the payments were for

  • Consulting fees$82510%
  • Travel & lodging$1752%
  • Food & beverage$6,73486%
  • Education$1282%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,862 in reported general payments places this provider in the 90th percentile of 565 psychiatric/mental health providers in Missouri.

See all psychiatric/mental health providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole14$23,380
Duloxetine Hcl19$254
Bupropion XlBupropion Hcl13$204
Quetiapine Fumarate12$162
Lamotrigine14$114
Sertraline Hcl12$109
Venlafaxine Hcl ErVenlafaxine Hcl11$79

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$512$23,38014 claims
Almatica Pharma LLCSertraline Hcl$46$10912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 565 psychiatric/mental health providers in Missouri.

Other psychiatric/mental health in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →